MedTrace Logo

Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition

NCT01395381 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-01-28

No results posted yet for this study

Summary

The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.

Conditions

  • Kwashiorkor
  • Marasmus

Interventions

DRUG

Placebo

placebo given once

DRUG

Albendazole

single dose albendazole given at the time of enrollment

Sponsors & Collaborators

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mark J Manary, MD · University of Malawi

  • Kenneth Maleta, MBBS PhD · University of Malawi

  • Indi Trehan, MD MPH DTM&H · University of Malawi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-01-31

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01395381 on ClinicalTrials.gov